drugset / Trial / NCT01257243

Comparison Between Oxomemazine, Guaifenesin and Potassium Iodate Versus Guaifenesin Monotherapy in Acute Cough Treatment

NCT01257243

Phase 3 Completed 260 enrolled EMS
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is evaluate if efficacy of a combination dose of oxomemazine, guaifenesin and potassium iodate is superior than guaifenesin monotherapy in acute cough treatment.

Timeline

Start
2012-10-01
Primary completion
2013-09-30
Completion
2013-10-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Guaifenesin Small molecule 5 ml
Subject Oxomemazine Small molecule
Subject Potassium iodate Unknown

Indications

No indication recorded.